Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Equity (2021 - 2025)

HCW Biologics (HCWB) has disclosed Return on Equity for 5 consecutive years, with 11.8% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 719.0% year-over-year to 11.8%, compared with a TTM value of 11.8% through Sep 2025, up 719.0%, and an annual FY2024 reading of 9.0%, down 798.0% over the prior year.
  • Return on Equity was 11.8% for Q3 2025 at HCW Biologics, up from 3.07% in the prior quarter.
  • Across five years, Return on Equity topped out at 11.8% in Q3 2025 and bottomed at 31.73% in Q2 2024.
  • Average Return on Equity over 5 years is 0.66%, with a median of 0.26% recorded in 2022.
  • The sharpest move saw Return on Equity tumbled -3109bps in 2024, then soared 3480bps in 2025.
  • Year by year, Return on Equity stood at 0.25% in 2021, then tumbled by -50bps to 0.38% in 2022, then plummeted by -266bps to 1.39% in 2023, then soared by 358bps to 3.6% in 2024, then soared by 228bps to 11.8% in 2025.
  • Business Quant data shows Return on Equity for HCWB at 11.8% in Q3 2025, 3.07% in Q2 2025, and 3.24% in Q1 2025.